38
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients

, , , , &
Pages 161-169 | Received 16 Nov 2004, Accepted 10 Jan 2005, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Philip R. Deitiker, Minako Oshima, R. Glenn Smith, Dennis R. Mosier & M. Zouhair Atassi. (2006) Subtle differences in HLA DQ haplotype-associated presentation of AChR α-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity 39:4, pages 277-288.
Read now

Articles from other publishers (6)

Huahua Zhong, Chongbo Zhao & Sushan Luo. (2019) HLA in myasthenia gravis: From superficial correlation to underlying mechanism. Autoimmunity Reviews 18:9, pages 102349.
Crossref
B. Vijayalakshmi Ayyar & M. Zouhair Atassi. (2017) Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis. Applied Microbiology and Biotechnology 101:22, pages 8165-8179.
Crossref
Hans D KatzbergVera Bril. (2009) Current and future immunotherapy in myasthenia gravis. Future Neurology 4:6, pages 745-759.
Crossref
Norbert Sommer, Björn Tackenberg & Reinhard Hohlfeld. 2008. Neuromuscular Junction Disorders. Neuromuscular Junction Disorders 169 212 .
Letizia ScolaDomenico LioAntonio CrivelloGiuseppina CandoreGiusi Irma ForteGiuseppina Colonna-RomanoMario Giovanni PesCiriaco CarruLuigi FerrucciLuca DeianaGiovannella BaggioClaudio FranceschiCalogero Caruso. (2006) Analysis of HLA-DQA, HLA-DQB Frequencies in a Group of Sardinian Centenarians. Rejuvenation Research 9:1, pages 157-160.
Crossref
Minako Oshima, Takahiro Maruta, Maki Ohtani, Philip R. Deitiker, DennisR. Mosier & M. Zouhair Atassi. (2006) Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. Journal of Neuroimmunology 171:1-2, pages 8-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.